Thomas J. McKearn

2.1k total citations · 1 hit paper
36 papers, 1.8k citations indexed

About

Thomas J. McKearn is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Molecular Biology. According to data from OpenAlex, Thomas J. McKearn has authored 36 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Radiology, Nuclear Medicine and Imaging, 17 papers in Immunology and 9 papers in Molecular Biology. Recurrent topics in Thomas J. McKearn's work include Monoclonal and Polyclonal Antibodies Research (18 papers), T-cell and B-cell Immunology (11 papers) and Radiopharmaceutical Chemistry and Applications (6 papers). Thomas J. McKearn is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (18 papers), T-cell and B-cell Immunology (11 papers) and Radiopharmaceutical Chemistry and Applications (6 papers). Thomas J. McKearn collaborates with scholars based in United States and Netherlands. Thomas J. McKearn's co-authors include Jennifer Bruce, Jonathan Sprent, Frank W. Symington, Frank W. Fitch, Frank P. Stuart, Roger H. Kennett, Kathleen B. Bechtol, John D. Rodwell, F. P. Stuart and Vernon L. Alvarez and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Thomas J. McKearn

36 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A monoclonal antibody discriminating between subsets of T and B cells.

1981 515 citations Thomas J. McKearn et al. The Journal of Immunology profile →

Peers

Countries citing papers authored by Thomas J. McKearn

Since Specialization

Citations

This map shows the geographic impact of Thomas J. McKearn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas J. McKearn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas J. McKearn more than expected).

Fields of papers citing papers by Thomas J. McKearn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas J. McKearn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas J. McKearn. The network helps show where Thomas J. McKearn may publish in the future.

Co-authorship network of co-authors of Thomas J. McKearn

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas J. McKearn. A scholar is included among the top collaborators of Thomas J. McKearn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas J. McKearn. Thomas J. McKearn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cost–effectiveness of treatments for high-risk myelodysplastic syndromes after failure of first-line hypomethylating agent therapy 2015 ·Expert Review of Pharmacoeconomics & Outcomes Research ·Christopher R. Cogle, Jesse D. Ortendahl, Tanya G. K. Bentley, (unknown), (unknown), Thomas J. McKearn, Michael E. Petrone, Sudipto Mukherjee	3
2	Multinational, Double-Blind, Phase III Study of Prednisone and Either Satraplatin or Placebo in Patients With Castrate-Refractory Prostate Cancer Progressing After Prior Chemotherapy: The SPARC Trial 2009 ·Journal of Clinical Oncology ·Cora N. Sternberg, Daniel P. Petrylak, Oliver Sartor, J. Alfred Witjes, Tomasz Demkow, Jean-Marc Ferrero, Jean-Christophe Eymard, S. Falcon, Fabio Calabrò, Nicholas D. James, I. Bodrogi, Peter Harper, Manfred Wirth, William Berry, Michael E. Petrone, Thomas J. McKearn, Mojtaba Noursalehi, Martine George, Marcel Rozencweig	262
3	Radioimmunodetection of solid tumors. Future horizons and applications for radioimmunotherapy 1993 ·Cancer ·Thomas J. McKearn	17
4	Radioimmunoscintigraphy and radioimmunotherapy in nude mouse models. Studies with site-specifically modified monoclonal antibodies. 1989 ·PubMed ·Vernon L. Alvarez, (unknown), John D. Rodwell, Thomas J. McKearn, (unknown)	2
5	Inhibition of mannosidase in hybridomas yields monoclonal antibodies with greater capacity for carbohydrate labeling. 1988 ·Clinical Chemistry ·(unknown), (unknown), Chongde Long, Ronald W. Gillette, Thomas J. McKearn, John D. Rodwell	1
6	Site-specifically modified 111In labelled antibodies give low liver backgrounds and improved radioimmunoscintigraphy 1986 ·International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology ·Vernon L. Alvarez, Mei-Li Wen, (unknown), (unknown), John D. Rodwell, Thomas J. McKearn	16
7	Site-specific covalent modification of monoclonal antibodies: in vitro and in vivo evaluations. 1986 ·Proceedings of the National Academy of Sciences ·John D. Rodwell, Vernon L. Alvarez, (unknown), (unknown), John Goers, Dalton King, (unknown), Thomas J. McKearn	189
8	Immunohistochemical application of monoclonal antibodies against myelin basic protein and neurofilament triple protein subunits: advantages over antisera and technical limitations. 1983 ·Journal of Histochemistry & Cytochemistry ·William F. Hickey, (unknown), John Q. Trojanowski, (unknown), Thomas J. McKearn, Jacqueline O. Gonatas, Nicholas K. Gonatas	54
9	Class I major histocompatibility gene products of the brown Norway rat display two major antigenic regions. 1982 ·The Journal of Immunology ·D M Klinman, Dawn E. Smilek, Thomas J. McKearn	9
10	A monoclonal antibody to an interspecies major histocompatibility determinant inhibits a virus-specific T-cell clone 1982 ·Cellular Immunology ·Michèle Allouche, Jack R. Bennink, Thomas J. McKearn, Peter C. Doherty	2
11	Dialyzable serum components can support the growth of hybridoma cell lines in vitro 1981 ·Journal of Immunological Methods ·Dennis M. Klinman, Thomas J. McKearn	10
12	Monoclonal antibodies : hybridomas, a new dimension in biological analyses 1980 ·Plenum Press eBooks ·Roger H. Kennett, Thomas J. McKearn, Kathleen B. Bechtol	99
13	Monoclonal rat anti-major histocompatibility complex antibodies display specificity for rat, mouse, and human target cells. 1980 ·The Journal of Experimental Medicine ·Dawn E. Smilek, (unknown), David B. Wilson, Chester M. Zmijewski, Frank W. Fitch, Thomas J. McKearn	38
14	Properties of Rat Anti‐MHC Antibodies Produced by Cloned Rat‐Mouse Hybridomas 1979 ·Immunological Reviews ·Thomas J. McKearn, Frank W. Fitch, Dawn E. Smilek, M Sarmiento, Frank P. Stuart	62
15	Ascites production in 9 rat strains 1979 ·Journal of Immunological Methods ·(unknown), (unknown), Thomas J. McKearn	6
16	Selective Suppression of Reactivity to Rat Histocompatibility Antigens by Hybridoma Antibodies 1979 ·PubMed ·Thomas J. McKearn, M Sarmiento, Arthur Weiss, Frank P. Stuart, Frank W. Fitch	23
17	Immunological enhancement of renal allografts by antireceptor antibody. 1976 ·PubMed ·Frank P. Stuart, Thomas J. McKearn, F W Fitch	9
18	Anti-idiotypic antibody in rat transplantation immunity. I. Production of anti-idiotypic antibody in animals repeatedly immunized with alloantigens. 1974 ·PubMed ·Thomas J. McKearn, F. P. Stuart, Frank W. Fitch	86
19	Antireceptor Antiserum Causes Specific Inhibition of Reactivity to Rat Histocompatibility Antigens 1974 ·Science ·Thomas J. McKearn	83
20	Anti-Idiotypic Antibody in Rat Transplantation Immunity 1974 ·The Journal of Immunology ·Thomas J. McKearn, Frank P. Stuart, Frank W. Fitch	48

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact